A study of stigmatized attitudes towards people with mental health problems among health professionals

Psychiatry, Tower Hamlets SAU, Mile End Hospital, London, UK.
Journal of Psychiatric and Mental Health Nursing (Impact Factor: 0.98). 05/2009; 16(3):279-84. DOI: 10.1111/j.1365-2850.2008.01369.x
Source: PubMed

ABSTRACT The project aimed to assess stigmatized attitudes among health professionals directed towards patients with mental health problems. The Attitude to Mental Illness Questionnaire was used to assess participants' attitudes towards fictitious patients from a secure forensic hospital and patients with schizophrenia and substance use disorders. Participants were health professionals from acute and mental health settings. In total, 108 completed questionnaires were received. Participants had highly stigmatized attitudes towards patients from a forensic hospital and those with active substance use disorders. Attitudes were less stigmatized to people with substance use disorders who were recovering in remission. This suggested that health professionals have stigmatized attitudes towards an illness such as schizophrenia and this is worse towards patients from a secure hospital. The manner in which patients with substance use disorder are presented can have a significant effect on stigmatized attitudes by health professionals.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite clinically relevant implications, stigma towards substance users remains an understudied area, especially in developing countries. This study aimed to find the extent of stigma towards substance use reported by substance users attending a de-addiction centre in India. Purposive sampling was used to recruit consenting fifty patients each dependent on alcohol and opioid from a tertiary care hospital in north India. Demographic and clinical details were recorded. The Stigma Scale and the Perceived Stigma of substance Abuse Scale (PSAS) were administered to both the groups to assess stigma. Alcohol dependent subjects reported higher stigma than the opioid dependent subjects on the Stigma Scale (t = 3.234, p = 0.018). Linear regression showed that duration of dependence, being employed and currently abstinent predicted greater stigma experienced as per the Stigma Scale. Presently being employed and higher per-capita income predicted lower perceived stigma towards substance users as per PSAS. Stigma in substance users remains a major clinical concern, minimizing which can help mitigate negative clinical consequences like delayed treatment seeking and reduced treatment compliance.
    International Journal of Mental Health and Addiction 02/2014; 13(1). DOI:10.1007/s11469-014-9514-1 · 0.95 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There is large gap in mental illness treatment globally and potentially especially so in war-affected populations. The study aim was to examine health care utilization patterns for mental, behavioural and emotional problems among the war-affected adult population in the Republic of Georgia. A cross-sectional household survey was conducted among 3600 adults affected by 1990s and 2008 armed conflicts in Georgia. Service use was measured for the last 12 months for any mental, emotional or behavioural problems. TSQ, PHQ-9 and GAD-7 were used to measure current symptoms of PTSD, depression and anxiety. Descriptive and regression analyses were used. Respondents were predominantly female (65.0%), 35.8% were unemployed, and 56.0% covered by the government insurance scheme. From the total sample, 30.5% had symptoms of at least one current mental disorder. Among them, 39.0% sought care for mental problems, while 33.1% expressed facing barriers to accessing care and so did not seek care. General practitioners (29%) and neurologists (26%) were consulted by the majority of those with a current mental disorder who accessed services, while use of psychiatric services was far more limited. Pharmacotherapy was the predominant type of care (90%). Female gender (OR 1.50, 95% CI: 1.25, 1.80), middle-age (OR 1.83, 95% CI: 1.48, 2.26) and older-age (OR 1.62, 95% CI: 1.19, 2.21), possession of the state insurance coverage (OR 1.55, 95% CI: 1.30, 1.86), current PTSD symptoms (OR 1.56, 95% CI: 1.29, 1.90) and depression (OR 2.12, 95% CI: 1.70, 2.65) were associated with higher rates of health service utilization, while employed were less likely to use services (OR 0.71, 95% CI: 0.55, 0.89). Reducing financial access barriers and increasing awareness and access to local care required to help reduce the burden of mental disorders among conflict-affected persons in Georgia.
    PLoS ONE 04/2015; 10(4):e0122673. DOI:10.1371/journal.pone.0122673 · 3.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Medicines are a major treatment modality for many mental illnesses, and with the growing burden of mental disorders worldwide pharmacists are ideally positioned to play a greater role in supporting people with a mental illness. This narrative review aims to describe the evidence for pharmacist-delivered services in mental health care and address the barriers and facilitators to increasing the uptake of pharmacist services as part of the broader mental health care team. This narrative review is divided into three main sections: (1) the role of the pharmacist in mental health care in multidisciplinary teams and in supporting early detection of mental illness; (2) the pharmacists' role in supporting quality use of medicines in medication review, strategies to improve medication adherence and antipsychotic polypharmacy, and shared decision making; and (3) barriers and facilitators to the implementation of mental health pharmacy services with a focus on organizational culture and mental health stigma. In the first section, the review presents new roles for pharmacists within multidisciplinary teams, such as in case conferencing or collaborative drug therapy management; and new roles that would benefit from increased pharmacist involvement, such as the early detection of mental health conditions, development of care plans and follow up of people with mental health problems. The second section describes the impact of medication review services and other pharmacist-led interventions designed to reduce inappropriate use of psychotropic medicines and improve medication adherence. Other new potential roles discussed include the management of antipsychotic polypharmacy and involvement in patient-centered care. Finally, barriers related to pharmacists' attitudes, stigma and skills in the care of patients with mental health problems and barriers affecting pharmacist-physician collaboration are described, along with strategies to reduce mental health stigma.
    International Journal of Environmental Research and Public Health 10/2014; 11(10):10967-10990. DOI:10.3390/ijerph111010967 · 1.99 Impact Factor